These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
301 related items for PubMed ID: 25500291
1. Erythropoietin activates the phosporylated cAMP [adenosine 3'5' cyclic monophosphate] response element-binding protein pathway and attenuates delayed paraplegia after ischemia-reperfusion injury. Mares JM, Foley LS, Bell MT, Bennett DT, Freeman KA, Meng X, Weyant MJ, Cleveland JC, Fullerton DA, Puskas F, Reece TB. J Thorac Cardiovasc Surg; 2015 Mar; 149(3):920-4. PubMed ID: 25500291 [Abstract] [Full Text] [Related]
2. Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion. Bell MT, Puskas F, Bennett DT, Herson PS, Quillinan N, Fullerton DA, Reece TB. J Thorac Cardiovasc Surg; 2014 Jan; 147(1):500-6. PubMed ID: 24035379 [Abstract] [Full Text] [Related]
8. Might erythropoietin save the spinal cord in aortic interventions? Melby SJ. J Thorac Cardiovasc Surg; 2015 Mar; 149(3):925-6. PubMed ID: 25583110 [No Abstract] [Full Text] [Related]
9. Erythropoietin attenuates neuronal injury and potentiates the expression of pCREB in anterior horn after transient spinal cord ischemia in rats. Sönmez A, Kabakçi B, Vardar E, Gürel D, Sönmez U, Orhan YT, Açikel U, Gökmen N. Surg Neurol; 2007 Sep; 68(3):297-303; discussion 303. PubMed ID: 17368520 [Abstract] [Full Text] [Related]
10. Protective effects of angiotensin II type-1 receptor blockade with olmesartan on spinal cord ischemia-reperfusion injury: an experimental study on rats. Güler A, Sahin MA, Ucak A, Onan B, Inan K, Oztaş E, Arslan S, Uysal B, Demirkiliç U, Tatar H. Ann Vasc Surg; 2010 Aug; 24(6):801-8. PubMed ID: 20638619 [Abstract] [Full Text] [Related]
12. Pretreatment With Diazoxide Attenuates Spinal Cord Ischemia-Reperfusion Injury Through Signaling Transducer and Activator of Transcription 3 Pathway. Yamanaka K, Eldeiry M, Aftab M, Ryan TJ, Roda G, Meng X, Weyant MJ, Cleveland JC, Fullerton DA, Reece TB. Ann Thorac Surg; 2019 Mar; 107(3):733-739. PubMed ID: 30395862 [Abstract] [Full Text] [Related]
13. Attenuation of spinal cord ischemia-reperfusion injury by specific α-2a receptor activation with dexmedetomidine. Bell MT, Puskas F, Smith PD, Agoston VA, Fullerton DA, Meng X, Weyant MJ, Reece TB. J Vasc Surg; 2012 Nov; 56(5):1398-402. PubMed ID: 22832266 [Abstract] [Full Text] [Related]
14. Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia. Bell MT, Agoston VA, Freeman KA, Puskas F, Herson PS, Mares J, Fullerton DA, Reece TB. J Vasc Surg; 2014 Apr; 59(4):1090-7. PubMed ID: 23850057 [Abstract] [Full Text] [Related]
17. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. Kiziltepe U, Turan NN, Han U, Ulus AT, Akar F. J Vasc Surg; 2004 Jul; 40(1):138-45. PubMed ID: 15218474 [Abstract] [Full Text] [Related]
18. Preservation of motor function after spinal cord ischemia and reperfusion injury through microglial inhibition. Smith PD, Bell MT, Puskas F, Meng X, Cleveland JC, Weyant MJ, Fullerton DA, Reece TB. Ann Thorac Surg; 2013 May; 95(5):1647-53. PubMed ID: 23541432 [Abstract] [Full Text] [Related]